PL395468A1 - Zwiazki amidoalkilopiperazynylowe do leczenia chorób osrodkowego ukladu nerwowego - Google Patents

Zwiazki amidoalkilopiperazynylowe do leczenia chorób osrodkowego ukladu nerwowego

Info

Publication number
PL395468A1
PL395468A1 PL395468A PL39546811A PL395468A1 PL 395468 A1 PL395468 A1 PL 395468A1 PL 395468 A PL395468 A PL 395468A PL 39546811 A PL39546811 A PL 39546811A PL 395468 A1 PL395468 A1 PL 395468A1
Authority
PL
Poland
Prior art keywords
nervous system
central nervous
alkilo
amido
treating diseases
Prior art date
Application number
PL395468A
Other languages
English (en)
Inventor
Zbigniew Majka
Marcin Kołaczkowski
Anna Czopek
Krzysztof Kamiński
Andrzej Miodoński
Maciej Pawłowski
Agnieszka Zagórska
Paweł Zajdel
Piotr Kowalski
Katarzyna Mitka
Jolanta Jaśkowska
Anna Wesołowska
Paweł Mierzejewski
Przemysław Bieńkowski
Original Assignee
Adamed Spólka Z Ograniczona Odpowiedzialnoscia
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Adamed Spólka Z Ograniczona Odpowiedzialnoscia filed Critical Adamed Spólka Z Ograniczona Odpowiedzialnoscia
Priority to PL395468A priority Critical patent/PL395468A1/pl
Priority to PCT/IB2012/053308 priority patent/WO2013001498A1/en
Publication of PL395468A1 publication Critical patent/PL395468A1/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PL395468A 2011-06-29 2011-06-29 Zwiazki amidoalkilopiperazynylowe do leczenia chorób osrodkowego ukladu nerwowego PL395468A1 (pl)

Priority Applications (2)

Application Number Priority Date Filing Date Title
PL395468A PL395468A1 (pl) 2011-06-29 2011-06-29 Zwiazki amidoalkilopiperazynylowe do leczenia chorób osrodkowego ukladu nerwowego
PCT/IB2012/053308 WO2013001498A1 (en) 2011-06-29 2012-06-28 Amidoalkylpiperazinyl derivatives for the treatment of central nervous system diseases

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PL395468A PL395468A1 (pl) 2011-06-29 2011-06-29 Zwiazki amidoalkilopiperazynylowe do leczenia chorób osrodkowego ukladu nerwowego

Publications (1)

Publication Number Publication Date
PL395468A1 true PL395468A1 (pl) 2013-01-07

Family

ID=46889379

Family Applications (1)

Application Number Title Priority Date Filing Date
PL395468A PL395468A1 (pl) 2011-06-29 2011-06-29 Zwiazki amidoalkilopiperazynylowe do leczenia chorób osrodkowego ukladu nerwowego

Country Status (2)

Country Link
PL (1) PL395468A1 (pl)
WO (1) WO2013001498A1 (pl)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN115353481A (zh) * 2022-08-31 2022-11-18 宁夏格瑞精细化工有限公司 一种顺式-1,2,3,6-四氢邻苯二甲酰亚胺的催化合成方法

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110204477B (zh) * 2019-05-09 2021-05-11 温州医科大学 一种具有抗氧化作用的二萜生物碱及其在制备药物中的应用

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA918659A (en) * 1969-07-31 1973-01-09 Yoshitomi Pharmaceutical Industries 11-(4-substituted-1-piperazinyl)-dibenzo (b,f) (1,4) thiazepines
US5538965A (en) 1993-12-23 1996-07-23 Allelix Biopharmaceuticals Inc. Dopamine receptor ligands
US5602120A (en) 1994-12-12 1997-02-11 Allelix Biopharmaceuticals, Inc. Benzyl-substituted compounds having dopamine receptor affinity
US6271225B1 (en) 1997-09-02 2001-08-07 Welfide Corporation Fused thiophene compounds and medicinal use thereof
WO2003082877A1 (en) * 2002-03-28 2003-10-09 Eli Lilly And Company Piperazine substituted aryl benzodiazepines and their use as dopamine receptor antagonists for the treatment of psychotic disorders
DK1546134T3 (da) * 2002-08-05 2007-09-10 Lilly Co Eli Piperazinsubstituerede arylbenzodiazepiner
PL195728B1 (pl) 2003-07-18 2007-10-31 Helm Ag Sposób wytwarzania 11-(1-piperazynylo)dibenzo[b,f][1,4]tiazepiny
EP1664063A1 (en) * 2003-09-09 2006-06-07 Eli Lilly And Company Substituted piperazines of azepines, oxazepines, and thiazepines
WO2006049734A2 (en) 2004-10-29 2006-05-11 Hypnion, Inc. Quetiapine analogs and methods of use thereof
PL198589B1 (pl) 2004-11-22 2008-06-30 Adamed Sp Z Oo Sposób wytwarzania N-demetyloolanzapiny
US7807828B2 (en) 2005-08-11 2010-10-05 Hypnion, Inc. Olanzapine analogs and methods of use thereof

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN115353481A (zh) * 2022-08-31 2022-11-18 宁夏格瑞精细化工有限公司 一种顺式-1,2,3,6-四氢邻苯二甲酰亚胺的催化合成方法
CN115353481B (zh) * 2022-08-31 2024-03-29 宁夏格瑞精细化工有限公司 一种顺式-1,2,3,6-四氢邻苯二甲酰亚胺的催化合成方法

Also Published As

Publication number Publication date
WO2013001498A1 (en) 2013-01-03

Similar Documents

Publication Publication Date Title
EA201700077A1 (ru) Соединения аминопиримидинила в качестве ингибиторов jak
UA109927C2 (ru) Конденсированные производные аминодигидротиазина, полезные как ингибиторы васе
EA201000314A1 (ru) 1',3'-двузамещенные-4-фенил-3,4,5,6-тетрагидро-2h,1'h-[1,4']бипиридинил-2'-оны
EA201000332A1 (ru) 1,3-двузамещенные 4-фенил-1н-пиридин-2-оны
JO3530B1 (ar) مركبات بيريدازين 1،4-ثنائية الإرتباط ونظائرها وطرق معالجة نقص smn وحالاته المرضية.
PH12014500326B1 (en) Heterocyclic derivative and pharmaceutical drug
GEP20207105B (en) 1,1,1-trifluoro-3-hydroxypropan-2-yl carbamate derivatives and 1,1,1-trifluoro-4-hydroxybutan-2yl carbamate derivatives as magl inhibitors
EA201790713A1 (ru) N-АЛКИЛАРИЛ-5-ОКСОАРИЛОКТАГИДРОЦИКЛОПЕНТА[c]ПИРРОЛЬНЫЕ НЕГАТИВНЫЕ АЛОСТЕРИЧЕСКИЕ МОДУЛЯТОРЫ NR2B
MX2013012776A (es) Inhibidores de la tirosina cinasa de bazo que contienen aminopiridina.
MX2009012418A (es) Derivados de quinazolin-oxima como inhibidores de hsp90.
UA106692C2 (uk) ІМІДАЗО[5,1-f][1,2,4]ТРИАЗИНИ ДЛЯ ЛІКУВАННЯ НЕВРОЛОГІЧНИХ РОЗЛАДІВ
UA108510C2 (xx) Циклопропанова сполука
EA200901159A1 (ru) Производные 3-циано-4-(4-фенилпиперидин-1-ил)пиридин-2-она
CR20200286A (es) DERIVADOS DE DIHIDRO-BENZO-OXAZINA Y DIHIDRO-PIRIDO-OXAZINA (Divisional 2014-0294)
WO2012042539A3 (en) 3 -azabicyclo [3.1.0] hexane compounds useful for the treatment of cns disorders
MX2010006063A (es) Derivados de 4-bencil-amino-pirrolidina 1,2-disustituida como inhibidores de la proteina de transferencia de colesteril-ester (cetp) utiles para el tratamiento de las enfermedades tales como hiperlipidemia o arterioesclerosis.
GEP20166483B (en) Phenyl-3-aza-bicyclo[3.1.0] hex-3-yl-methanones and the use thereof as medicament
PH12020550168A1 (en) Griseofulvin compound and pharmaceutical use thereof
NZ703064A (en) Inhibitors of hepatitis c virus
PH12021550742A1 (en) Indolinone compounds for use as map4k1 inhibitors
PH12017502009A1 (en) Novel sulfonimidoylpurinone compounds and derivatives for the treatment and prophylaxis of virus infection
EA201270359A1 (ru) Терапевтическое средство от расстройств настроения
PH12018502457A1 (en) Treatment for parkinson's disease
MX341341B (es) Derivados de benzamida y su uso como inhibidores de proteina de choque termico 90 kda (hsp90).
SG10201806809QA (en) 1-heterocyclyl isochromanyl compounds and analogs for treating cns disorders

Legal Events

Date Code Title Description
REFS Decisions on refusal to grant patents (taken after the publication of the particulars of the applications)